Federal Appeals Court Breathes New Life into Lawsuit Against FDA's COVID-19 Ivermectin Messaging

A federal appeals court has revived a lawsuit against the FDA over its campaign against the use of ivermectin to treat COVID-19. Three doctors sued the FDA, claiming that the agency's anti-ivermectin messaging went beyond its authority. The court ruled that the lawsuit can continue, stating that the FDA's messaging crossed the line between informing and advising. The FDA's campaign emphasized that ivermectin should not be used to treat COVID-19, despite its approval for other uses. The drug's effectiveness for COVID-19 treatment remains controversial, with limited high-quality evidence supporting its use. The World Health Organization and the National Institutes of Health have also recommended against its use. The doctors claim that their reputations were harmed by the FDA campaign.